A carregar...
Combination therapy for inflammatory bowel disease
Biologic therapies such as infliximab and adalimumab have become mainstays of treatment for inflammatory bowel disease. Early studies suggested that combination therapy (CT) with infliximab and an immunomodulator drug such as azathioprine may help optimize biologic pharmacokinetics, minimize immunog...
Na minha lista:
| Publicado no: | World J Gastrointest Pharmacol Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5421108/ https://ncbi.nlm.nih.gov/pubmed/28533919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v8.i2.103 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|